speb/financial-data huggingface dataset:
Financial ratios for BBLG — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -748075
Net income: -740519
Capital expenditures: 0
Operating cash flow: -458879
Net tangible assets: 6596074
Owner earnings: -740519
Return on net tangible assets (%): -11.226663011967423
Buffett classification: The Gruesome
Stock price: 4.03
Shares outstanding: 1795260
Book value: 6596074
P/B ratio: 1.0968490953861343
Market cap (USD): 7234897.800000001
Debt to equity: 0
Current ratio: 17.240807402337115
Quick ratio: 17.240807402337115
Free cash flow (dilution-adjusted): -531778
Buyback yield (%): 0
Retained earnings: -86778989
Capitalized R&D asset: 475403.92000000004
ROCI (R&D-adjusted, %): -10.76901238960997
Rule of 40 score: 0
Financial ratios for BBLG — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -715274
Net income: -666737
Capital expenditures: 0
Operating cash flow: -591384
Net tangible assets: 6016517
Owner earnings: -666737
Return on net tangible assets (%): -11.081777048082802
Buffett classification: The Gruesome
Stock price: 2.79
Shares outstanding: 1795260
Book value: 6016517
P/B ratio: 0.8325041548124937
Market cap (USD): 5008775.4
Debt to equity: 0
Current ratio: 18.998327759197323
Quick ratio: 18.998327759197323
Free cash flow (dilution-adjusted): -678564
Buyback yield (%): 0
Retained earnings: -87445726
Capitalized R&D asset: 455965.44
ROCI (R&D-adjusted, %): -12.284776472873675
Rule of 40 score: 0
Financial ratios for BBLG — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -733105
Net income: -684643
Capital expenditures: 0
Operating cash flow: -714762
Net tangible assets: 5377548
Owner earnings: -684643
Return on net tangible assets (%): -12.731508858684293
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 1795260
Book value: 5377548
P/B ratio: 0.4840732244509951
Market cap (USD): 2603127
Debt to equity: 0
Current ratio: 13.8469063778856
Quick ratio: 13.8469063778856
Free cash flow (dilution-adjusted): -760436
Buyback yield (%): 0
Retained earnings: -88130369
Receivables turnover: 0
Capitalized R&D asset: 446259
ROCI (R&D-adjusted, %): -11.815507164528862
Rule of 40 score: 0
Financial ratios for BBLG — annual report dated 2025-12-31
Total revenue: 0
Operating income: -3234942
Net income: -3108991
Capital expenditures: 0
Operating cash flow: -2691150
Net tangible assets: 5377548
Owner earnings: -3108991
Return on net tangible assets (%): -57.81428636248342
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 1795260
Book value: 5377548
P/B ratio: 0.4840732244509951
Market cap (USD): 2603127
Debt to equity: 0
Current ratio: 13.8469063778856
Quick ratio: 13.8469063778856
Free cash flow (dilution-adjusted): -2947508
Buyback yield (%): 0
Retained earnings: -88130369
Receivables turnover: 0
Capitalized R&D asset: 4767130.87
ROCI (R&D-adjusted, %): -54.618627206810075
Rule of 40 score: 0
Financial ratios for BEL.AX — annual report dated 2021-06-30
Total revenue: 9011336.090225564
Net income: 7844997.744360901
Capital expenditures: 1027.8195488721803
Depreciation & amortization: 1718.0451127819547
Net tangible assets: 11761051.879699247
Owner earnings: 7845687.969924811
Return on net tangible assets (%): 66.7090669285054
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
P/E ratio: 0.7296246341354249
Shares outstanding: 76127918
Book value: 11761051.879699247
P/B ratio: 0.48668296573902436
Market cap (USD): 5723903.609022556
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 13.605678127891876
Free cash flow (dilution-adjusted): 659269.1729323308
Buyback yield (%): 0.019703678222225914
Retained earnings: -13210433.834586466
Receivables turnover: 150.8885433715221
Capitalized R&D asset: 0
FCF margin (%): 7.315998053245715
Rule of 40 score: 7.315998053245715
Financial ratios for BEL.AX — annual report dated 2022-06-30
Total revenue: -5490125.517241379
Net income: -5962888.275862069
Capital expenditures: 0
Depreciation & amortization: 1201.3793103448277
Net tangible assets: 4824835.172413793
Owner earnings: -5961686.896551724
Return on net tangible assets (%): -123.56249868675162
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 76127918
Book value: 4824835.172413792
P/B ratio: 0.6528970694871693
Market cap (USD): 3150120.744827586
Debt to equity: 0
Free cash flow (dilution-adjusted): -508097.2413793104
Buyback yield (%): 0.007093324160001329
Retained earnings: -18177494.482758623
Receivables turnover: -30.746551930571275
Capitalized R&D asset: 0
Revenue growth (%): -160.92465603626104
Rule of 40 score: -160.92465603626104
Financial ratios for BEL.AX — annual report dated 2023-06-30
Total revenue: -1943568.8741721853
Net income: -2371862.251655629
Capital expenditures: 0
Depreciation & amortization: 708.6092715231788
Net tangible assets: 2261257.6158940396
Owner earnings: -2371153.642384106
Return on net tangible assets (%): -104.85995163565724
Buffett classification: The Gruesome
Stock price: 0.033112582781456956
Shares outstanding: 76127918
Book value: 2261257.6158940396
P/B ratio: 1.114774349033343
Market cap (USD): 2520791.986754967
Debt to equity: 0
Free cash flow (dilution-adjusted): 136703.97350993377
Buyback yield (%): 0.002469527670518981
Retained earnings: -19827072.185430463
Receivables turnover: -150.34779713114753
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEL.AX — annual report dated 2024-06-30
Total revenue: -736296
Net income: -1359046.6666666667
Capital expenditures: 0
Depreciation & amortization: 266
Net tangible assets: 913904.6666666666
Owner earnings: -1358780.6666666667
Return on net tangible assets (%): -148.67860032082123
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 76127918
Book value: 913904.6666666667
P/B ratio: 1.1106616955670796
Market cap (USD): 1015038.9066666667
Debt to equity: 0
Free cash flow (dilution-adjusted): 172638.66666666666
Buyback yield (%): 0.01352985904592846
Retained earnings: -21379312
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.44318181818182
Shares outstanding: 2042071247
Market cap (USD): 103008571198.10228
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.DE — annual report dated 2022-12-31
Total revenue: 46159000000
Gross profit: 36022000000
Operating income: 9104000000
Net income: 6345000000
Capital expenditures: 1118000000
Operating cash flow: 13066000000
Depreciation & amortization: 10276000000
Net tangible assets: -26443000000
Owner earnings: 15503000000
Return on net tangible assets (%): -58.6279922852929
Capex to operating income (%): 12.280316344463973
Buffett classification: The Great
Stock price: 60.11702127659574
P/E ratio: 19.3480284640226
Shares outstanding: 2042071247
Book value: 31118000000
P/B ratio: 3.9450877499911114
Market cap (USD): 122763240604.2234
Debt to equity: 1.3084709814255415
Current ratio: 1.2459113750571038
Quick ratio: 1.13905893101873
Effective tax rate (%): 17.736289381563594
Interest coverage ratio: 7.3896103896103895
COGS to revenue (%): 21.96104768300873
R&D to revenue (%): 20.60053294048831
SG&A to revenue (%): 16.928442990532723
Free cash flow (dilution-adjusted): 11491000000
Buyback yield (%): 6.5174232617355194
Retained earnings: 25503000000
Inventory turnover: 4.333903377511757
Receivables turnover: 3.3119753175001794
Capitalized R&D asset: 9509000000
ROCI (R&D-adjusted, %): 18.289337075679878
FCF margin (%): 24.89438679347473
Rule of 40 score: 24.89438679347473
Financial ratios for BRM.DE — annual report dated 2023-12-31
Total revenue: 45006000000
Gross profit: 34313000000
Operating income: 8195000000
Net income: 8040000000
Capital expenditures: 1209000000
Operating cash flow: 13860000000
Depreciation & amortization: 9760000000
Net tangible assets: -19224000000
Owner earnings: 16591000000
Return on net tangible assets (%): -86.30357885975863
Capex to operating income (%): 14.752898108602807
Buffett classification: The Great
Stock price: 44.56666666666666
P/E ratio: 11.319441365004145
Shares outstanding: 2042071247
Book value: 29485000000
P/B ratio: 3.0865968653428295
Market cap (USD): 91008308574.63333
Debt to equity: 1.4062743768017636
Current ratio: 1.4270954990566884
Quick ratio: 1.3075195400233581
Effective tax rate (%): 4.739336492890995
Interest coverage ratio: 7.028301886792453
COGS to revenue (%): 23.759054348309114
R&D to revenue (%): 20.66168955250411
SG&A to revenue (%): 17.26880860329734
Free cash flow (dilution-adjusted): 12133000000
Buyback yield (%): 5.664317995507554
Retained earnings: 28766000000
Inventory turnover: 4.016904583020286
Receivables turnover: 2.948506289308176
Capitalized R&D asset: 15670030000
ROCI (R&D-adjusted, %): 12.673640142010708
Rosenberg metric: -0.17972447155326532
FCF margin (%): 26.958627738523756
Revenue growth (%): -2.4978877358694946
Rule of 40 score: 24.460740002654262
Financial ratios for BRM.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46
Shares outstanding: 2042071247
Market cap (USD): 93935277362
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.DE — annual report dated 2024-12-31
Total revenue: 48300000000
Gross profit: 34332000000
Operating income: 5887000000
Net income: -8933000000
Capital expenditures: 1248000000
Operating cash flow: 15190000000
Depreciation & amortization: 9600000000
Net tangible assets: -29027000000
Owner earnings: -581000000
Capex to operating income (%): 21.19925259045354
Buffett classification: The Great
Stock price: 52.40625000000001
Shares outstanding: 2042071247
Book value: 16388000000
P/B ratio: 6.530223107645458
Market cap (USD): 107017296288.09377
Debt to equity: 3.1242372467659263
Current ratio: 1.2526289223521494
Quick ratio: 1.145074451081013
Interest coverage ratio: 3.0236260914227016
COGS to revenue (%): 28.91925465838509
R&D to revenue (%): 23.10351966873706
SG&A to revenue (%): 17.42028985507246
Free cash flow (dilution-adjusted): 13435000000
Buyback yield (%): 0
Retained earnings: 14912000000
Inventory turnover: 5.462651544779038
Receivables turnover: 3.348585690515807
Capitalized R&D asset: 20527300000
ROCI (R&D-adjusted, %): 7.897596476129831
Rosenberg metric: 0.0020432304548876224
FCF margin (%): 27.815734989648032
Revenue growth (%): 7.319024130115985
Rule of 40 score: 35.13475911976402
Financial ratios for BRM.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.40625000000001
Shares outstanding: 2042071247
Market cap (USD): 107017296288.09377
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.DE — quarterly report dated 2025-03-31
Total revenue: 11201000000
Gross profit: 8168000000
Operating income: 3497000000
Net income: 2462000000
Capital expenditures: 260000000
Operating cash flow: 1954000000
Depreciation & amortization: 1012000000
Net tangible assets: -27150000000
Owner earnings: 3214000000
Return on net tangible assets (%): -11.837937384898712
Capex to operating income (%): 7.434944237918216
Buffett classification: The Great
Stock price: 56.78260869565217
P/E ratio: 11.77438388982976
Shares outstanding: 2042071247
Book value: 17448000000
P/B ratio: 6.64569764712537
Market cap (USD): 115954132547.04347
Debt to equity: 2.936668959193031
Current ratio: 1.2788948899044454
Quick ratio: 1.1681346073950976
Effective tax rate (%): 17.13227869404241
Interest coverage ratio: 7.078947368421052
COGS to revenue (%): 27.077939469690204
R&D to revenue (%): 20.14998660833854
SG&A to revenue (%): 14.141594500491028
Free cash flow (dilution-adjusted): 1550000000
Buyback yield (%): 0
Retained earnings: 16106000000
Inventory turnover: 1.1376594148537134
Receivables turnover: 0.7679281502810914
Capitalized R&D asset: 2257000000
ROCI (R&D-adjusted, %): 7.083109109619434
FCF margin (%): 13.838050174091599
Rule of 40 score: 13.838050174091599
Financial ratios for BRM.DE — quarterly report dated 2025-06-30
Total revenue: 12269000000
Gross profit: 8897000000
Operating income: 3774000000
Net income: 1313000000
Capital expenditures: 361000000
Operating cash flow: 3917000000
Depreciation & amortization: 1011000000
Net tangible assets: -26004000000
Owner earnings: 1963000000
Return on net tangible assets (%): -7.548838640209199
Capex to operating income (%): 9.565447800741918
Buffett classification: The Great
Stock price: 43.588235294117645
P/E ratio: 23.578882649427346
Shares outstanding: 2042071247
Book value: 17489000000
P/B ratio: 5.0895009435409815
Market cap (USD): 89010282001.58823
Debt to equity: 2.9120590085196407
Current ratio: 1.2068439407149085
Quick ratio: 1.1074179017727406
Effective tax rate (%): 25.944726452340667
Interest coverage ratio: 7.781443298969072
COGS to revenue (%): 27.48390251854267
R&D to revenue (%): 21.028608688564677
SG&A to revenue (%): 13.96201809438422
Free cash flow (dilution-adjusted): 3419000000
Buyback yield (%): 0
Retained earnings: 16154000000
Inventory turnover: 1.2320058458165875
Receivables turnover: 0.8124627508112046
Capitalized R&D asset: 4092190000
ROCI (R&D-adjusted, %): 6.655887170804382
Rosenberg metric: 0.3229951262738148
FCF margin (%): 27.866981824109544
Revenue growth (%): 9.534862958664405
Rule of 40 score: 37.40184478277395
Financial ratios for BRM.DE — quarterly report dated 2025-09-30
Total revenue: 12222000000
Gross profit: 8787000000
Operating income: 3639000000
Net income: 2201000000
Capital expenditures: 320000000
Operating cash flow: 6311000000
Depreciation & amortization: 1011000000
Net tangible assets: -23918000000
Owner earnings: 2892000000
Return on net tangible assets (%): -12.091311982607241
Capex to operating income (%): 8.793624622148942
Buffett classification: The Great
Stock price: 42.77647058823529
P/E ratio: 14.617235715591777
Shares outstanding: 2042071247
Book value: 18600000000
P/B ratio: 4.69637637829981
Market cap (USD): 87352600636.37646
Debt to equity: 2.7441397849462366
Current ratio: 1.2663491612169462
Quick ratio: 1.1683252772249075
Effective tax rate (%): 29.511881824020552
Interest coverage ratio: 7.58125
COGS to revenue (%): 28.10505645557192
R&D to revenue (%): 20.684012436589754
SG&A to revenue (%): 14.63753886434299
Free cash flow (dilution-adjusted): 5852000000
Buyback yield (%): 0
Retained earnings: 17093000000
Inventory turnover: 1.2454677302393038
Receivables turnover: 0.8362068965517241
Capitalized R&D asset: 5001410000
ROCI (R&D-adjusted, %): 5.032919387464424
Rosenberg metric: -0.04263565891472868
FCF margin (%): 47.88087056128293
Revenue growth (%): -0.38307930556687586
Rule of 40 score: 47.49779125571606
Financial ratios for BRM.DE — annual report dated 2025-12-31
Total revenue: 48195000000
Gross profit: 34259000000
Operating income: 13724000000
Net income: 7055000000
Capital expenditures: 1311000000
Operating cash flow: 14156000000
Depreciation & amortization: 4011000000
Net tangible assets: -22634000000
Owner earnings: 9755000000
Return on net tangible assets (%): -43.0988777944685
Capex to operating income (%): 9.552608568930342
Buffett classification: The Great
Stock price: 52.07058823529412
P/E ratio: 15.071842813560679
Shares outstanding: 2042071247
Book value: 18506000000
P/B ratio: 5.745804120267512
Market cap (USD): 106331851049.6706
Debt to equity: 2.547227926078029
Current ratio: 1.2550711021907162
Quick ratio: 1.1401972925652304
Effective tax rate (%): 24.356775300171527
Interest coverage ratio: 7.25753569539926
COGS to revenue (%): 28.915862641352835
R&D to revenue (%): 20.647370059134765
SG&A to revenue (%): 15.078327627347235
Free cash flow (dilution-adjusted): 12292000000
Buyback yield (%): 0
Retained earnings: 16896000000
Inventory turnover: 5.180669144981413
Receivables turnover: 3.3180722891566266
Capitalized R&D asset: 20496200000
ROCI (R&D-adjusted, %): 15.540750467951984
Rosenberg metric: -0.0065418048212205395
FCF margin (%): 25.50472040668119
Revenue growth (%): -0.21739130434782608
Rule of 40 score: 25.287329102333366
Financial ratios for BRM.DE — quarterly report dated 2025-12-31
Total revenue: 12503000000
Gross profit: 8406000000
Operating income: 2813000000
Net income: 1087000000
Capital expenditures: 370000000
Operating cash flow: 1974000000
Depreciation & amortization: 977000000
Net tangible assets: -22634000000
Owner earnings: 1694000000
Return on net tangible assets (%): -7.484315631351064
Capex to operating income (%): 13.153217205830076
Buffett classification: The Great
Stock price: 52.07058823529412
P/E ratio: 15.054771492237093
Shares outstanding: 2042071247
Book value: 18506000000
P/B ratio: 5.745804120267512
Market cap (USD): 106331851049.6706
Debt to equity: 2.547227926078029
Current ratio: 1.2550711021907162
Quick ratio: 1.1401972925652304
Effective tax rate (%): 26.122448979591837
Interest coverage ratio: 6.511574074074074
COGS to revenue (%): 32.768135647444616
R&D to revenue (%): 20.68303607134288
SG&A to revenue (%): 17.443813484763655
Free cash flow (dilution-adjusted): 1471000000
Buyback yield (%): 0
Retained earnings: 16896000000
Inventory turnover: 1.5230483271375466
Receivables turnover: 0.8607917383820999
Capitalized R&D asset: 5131160000
ROCI (R&D-adjusted, %): 3.9501714419932914
Rosenberg metric: -0.1507120253164557
FCF margin (%): 11.765176357674157
Revenue growth (%): 2.299132711503846
Rule of 40 score: 14.064309069178003
Financial ratios for BRNL.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10
Shares outstanding: 50332880
Market cap (USD): 503328800
Buyback yield (%): 0.446346584795249
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.AS — annual report dated 2022-12-31
Total revenue: 1257259574.4680853
Gross profit: 268208510.6382979
Operating income: 64759574.46808511
Net income: 32727659.574468087
Capital expenditures: 3232978.7234042557
Operating cash flow: 28013829.787234046
Depreciation & amortization: 22689361.70212766
Net tangible assets: 254230851.0638298
Owner earnings: 52184042.55319149
Return on net tangible assets (%): 20.526243111261753
Capex to operating income (%): 4.992279133948813
Buffett classification: The Great
Stock price: 8.329787234042554
P/E ratio: 12.810637446365881
Shares outstanding: 50332880
Book value: 338103191.4893617
P/B ratio: 1.2400420694928214
Market cap (USD): 419262181.2765958
Debt to equity: 0.20218868090756634
Current ratio: 2.5277902631342384
Quick ratio: 2.5277902631342384
Effective tax rate (%): 35.239137756820476
Interest coverage ratio: 51.89599317988064
COGS to revenue (%): 78.66721271526048
Free cash flow (dilution-adjusted): 16225531.914893618
Buyback yield (%): 0
Retained earnings: 31265957.446808513
Receivables turnover: 4.178566630131174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.552807599347984
FCF margin (%): 1.2905474926892666
Rule of 40 score: 1.2905474926892666
Financial ratios for BRNL.AS — annual report dated 2023-12-31
Total revenue: 1478372222.222222
Gross profit: 303980000
Operating income: 62578888.88888889
Net income: 35732222.222222224
Capital expenditures: 3312222.222222222
Operating cash flow: 8592222.222222222
Depreciation & amortization: 24465555.555555556
Net tangible assets: 258365555.55555555
Owner earnings: 56885555.55555555
Return on net tangible assets (%): 22.01746878883924
Capex to operating income (%): 5.292874771399656
Buffett classification: The Great
Stock price: 10.633333333333333
P/E ratio: 14.978253726794986
Shares outstanding: 50332880
Book value: 347261111.1111111
P/B ratio: 1.541221500311965
Market cap (USD): 535206290.6666666
Debt to equity: 0.39291599340873823
Current ratio: 2.5944348682590497
Quick ratio: 2.5944348682590497
Effective tax rate (%): 35.81294159913776
Interest coverage ratio: 13.308364839319472
COGS to revenue (%): 79.43819591367382
SG&A to revenue (%): 0.10920419229858667
Free cash flow (dilution-adjusted): -6357777.777777778
Buyback yield (%): 0
Retained earnings: 35168888.88888889
Receivables turnover: 4.056199984757259
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.019186315302822
FCF margin (%): -0.4300525728372422
Revenue growth (%): 17.58687324752997
Rule of 40 score: 17.156820674692728
Financial ratios for BRNL.AS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.755555555555555
Shares outstanding: 50332880
Market cap (USD): 440692327.11111104
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 253087500
Buffett classification: The Gruesome
Stock price: 8.489583333333334
Shares outstanding: 50332880
Book value: 330622916.6666666
P/B ratio: 1.2924245647420591
Market cap (USD): 427305179.1666667
Debt to equity: 0.3018103453707963
Current ratio: 2.675881359318524
Quick ratio: 2.675881359318524
Buyback yield (%): 0
Retained earnings: 31085416.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.AS — annual report dated 2024-12-31
Total revenue: 1421625000
Gross profit: 274048958.3333334
Operating income: 54321875
Net income: 31513541.666666668
Capital expenditures: 2725000
Operating cash flow: 99748958.33333334
Depreciation & amortization: 22809375
Net tangible assets: 253088541.6666667
Owner earnings: 51597916.66666667
Return on net tangible assets (%): 20.387298582100303
Capex to operating income (%): 5.016395328769487
Buffett classification: The Great
Stock price: 8.489583333333334
P/E ratio: 13.559414669619542
Shares outstanding: 50332880
Book value: 330622916.6666666
P/B ratio: 1.2924245647420591
Market cap (USD): 427305179.1666667
Debt to equity: 0.3018103453707963
Current ratio: 2.675881359318524
Quick ratio: 2.675881359318524
Effective tax rate (%): 31.68567234955403
COGS to revenue (%): 80.72283771505613
SG&A to revenue (%): 0.15328702482487766
Free cash flow (dilution-adjusted): 90627083.33333333
Buyback yield (%): 0
Retained earnings: 31085416.666666668
Receivables turnover: 4.794991251554694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.510795716259787
FCF margin (%): 6.374893754213194
Revenue growth (%): -3.838493538313527
Rule of 40 score: 2.5364002158996675
Financial ratios for BRNL.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 232209411.7647059
Buffett classification: The Gruesome
Stock price: 10.058823529411766
Shares outstanding: 50332880
Book value: 317591764.7058823
P/B ratio: 1.5941520338725634
Market cap (USD): 506289557.6470589
Debt to equity: 0.3241860620182032
Quick ratio: 0
Buyback yield (%): 0
Retained earnings: 357647.0588235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.AS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.117647058823529
Shares outstanding: 50332880
Market cap (USD): 458917435.2941176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.AS — annual report dated 2025-12-31
Total revenue: 1432536470.5882354
Gross profit: 256604705.88235295
Operating income: 20250588.23529412
Net income: 5344705.882352942
Capital expenditures: 2445882.3529411764
Operating cash flow: 37175294.11764706
Depreciation & amortization: 32328235.29411765
Net tangible assets: 228947058.82352942
Owner earnings: 35227058.823529415
Return on net tangible assets (%): 15.386552246859022
Capex to operating income (%): 12.078080520536803
Buffett classification: The Great
Stock price: 8.71764705882353
P/E ratio: 82.0969933524103
Shares outstanding: 50332880
Book value: 317694117.64705884
P/B ratio: 1.3811533135831728
Market cap (USD): 438784283.2941177
Debt to equity: 0.3928788327655162
Current ratio: 2.3929913153786107
Quick ratio: 2.3929913153786107
Effective tax rate (%): 62.627509049029285
Interest coverage ratio: 3.626843657817109
COGS to revenue (%): 82.08738757087387
SG&A to revenue (%): 0.1571872515718725
Free cash flow (dilution-adjusted): 25020000
Buyback yield (%): 0
Retained earnings: 3591764.7058823532
Receivables turnover: 4.601474550587062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.598078813523101
FCF margin (%): 1.7465523924655237
Revenue growth (%): 0.7675350805054342
Rule of 40 score: 2.514087472970958
Financial ratios for BRNL.AS — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 228947058.82352942
Buffett classification: The Gruesome
Stock price: 8.71764705882353
Shares outstanding: 50332880
Book value: 317694117.64705884
P/B ratio: 1.3811533135831728
Market cap (USD): 438784283.2941177
Debt to equity: 0.3928788327655162
Current ratio: 2.3929913153786107
Quick ratio: 2.3929913153786107
Buyback yield (%): 0
Retained earnings: 3591764.7058823532
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.8
Shares outstanding: 30331425
Market cap (USD): 297247965
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTMD — annual report dated 2022-12-31
Total revenue: 164957000
Gross profit: 110382000
Operating income: -60722000
Net income: 1324000
Capital expenditures: 333000
Operating cash flow: -9157000
Depreciation & amortization: 2199000
Net tangible assets: -49532000
Owner earnings: 3190000
Return on net tangible assets (%): -6.440281030444965
Buffett classification: The Gruesome
Stock price: 3.73
P/E ratio: 85.4503136329305
Shares outstanding: 30331425
Book value: -58274000
Market cap (USD): 113136215.25
Debt to equity: -2.0665820091292857
Current ratio: 5.391559202813599
Quick ratio: 4.795641052968134
Effective tax rate (%): 22.66355140186916
Interest coverage ratio: -15.004200642451199
COGS to revenue (%): 33.08437956558376
SG&A to revenue (%): 103.72642567456974
Free cash flow (dilution-adjusted): -93175000
Buyback yield (%): 0.3747694750642633
Retained earnings: -44460000
Inventory turnover: 4.880175266028794
Receivables turnover: 23.741652274035694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.37753421117797
FCF margin (%): -56.484417151136356
Rule of 40 score: -56.484417151136356
Financial ratios for BTMD — annual report dated 2023-12-31
Total revenue: 185360000
Gross profit: 127483000
Operating income: 28657000
Net income: 3316000
Capital expenditures: 359000
Operating cash flow: 26883000
Depreciation & amortization: 2994000
Net tangible assets: -34370000
Owner earnings: 5951000
Return on net tangible assets (%): -17.314518475414605
Capex to operating income (%): 1.2527480196810552
Buffett classification: The Great
Stock price: 4.94
P/E ratio: 45.18613977683957
Shares outstanding: 30331425
Book value: -36546000
Market cap (USD): 149837239.5
Debt to equity: -3.1431894051332567
Current ratio: 5.507224848075625
Quick ratio: 4.728156650911546
Interest coverage ratio: 4.503693226465503
COGS to revenue (%): 31.22410444540354
SG&A to revenue (%): 53.315709969788514
Free cash flow (dilution-adjusted): 15113000
Buyback yield (%): 0
Retained earnings: -29391000
Inventory turnover: 3.344138209972843
Receivables turnover: 22.676780034254953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.5336639615269
FCF margin (%): 8.153323262839878
Revenue growth (%): 12.368677897876417
Rule of 40 score: 20.522001160716293
Financial ratios for BTMD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.58
Shares outstanding: 30331425
Market cap (USD): 169249351.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.18
Shares outstanding: 30331425
Market cap (USD): 187448206.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTMD — annual report dated 2024-12-31
Total revenue: 197191000
Gross profit: 139061000
Operating income: 31611000
Net income: 3157000
Capital expenditures: 6430000
Operating cash flow: 45243000
Depreciation & amortization: 3574000
Net tangible assets: -121138000
Owner earnings: 301000
Return on net tangible assets (%): -0.24847694365104261
Capex to operating income (%): 20.341020530827876
Buffett classification: The Great
Stock price: 6.18
P/E ratio: 59.37542176116566
Shares outstanding: 30331425
Book value: -102200000
Market cap (USD): 187448206.5
Debt to equity: -1.0847553816046966
Current ratio: 1.3224948557673641
Quick ratio: 1.0343207671700896
Effective tax rate (%): 95.47244094488188
Interest coverage ratio: 2.873466048541042
COGS to revenue (%): 29.479033018748318
SG&A to revenue (%): 54.49031649517473
Free cash flow (dilution-adjusted): 29552000
Buyback yield (%): 2.9869584268334948
Retained earnings: -100297000
Inventory turnover: 3.9157965644998316
Receivables turnover: 25.60257076084134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.61301795190245
FCF margin (%): 14.98648518441511
Revenue growth (%): 6.382714717306863
Rule of 40 score: 21.369199901721974
Financial ratios for BTMD — quarterly report dated 2025-03-31
Total revenue: 48992000
Gross profit: 36382000
Operating income: 9690000
Net income: 15839000
Capital expenditures: 1630000
Operating cash flow: 6467000
Depreciation & amortization: 857000
Net tangible assets: -104766000
Owner earnings: 15066000
Return on net tangible assets (%): -14.380619666685757
Capex to operating income (%): 16.821465428276575
Buffett classification: The Great
Stock price: 3.33
P/E ratio: 1.5942238343645432
Shares outstanding: 30331425
Book value: -84826000
Market cap (USD): 101003645.25
Debt to equity: -1.2895102916558603
Current ratio: 1.4169589436765009
Quick ratio: 1.1394470806684547
Effective tax rate (%): 9.258092237181323
Interest coverage ratio: 3.3356282271944924
COGS to revenue (%): 25.738896146309603
SG&A to revenue (%): 54.48236446766819
Free cash flow (dilution-adjusted): 2492000
Buyback yield (%): 0
Retained earnings: -84346000
Inventory turnover: 0.9374767675265779
Receivables turnover: 6.309336767546684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.93569531030984
FCF margin (%): 5.0865447419986936
Rule of 40 score: 5.0865447419986936
Financial ratios for BTMD — quarterly report dated 2025-06-30
Total revenue: 48863000
Gross profit: 34988000
Operating income: 10765000
Net income: 3925000
Capital expenditures: 1809000
Operating cash flow: 7086000
Depreciation & amortization: 910000
Net tangible assets: -99402000
Owner earnings: 3026000
Return on net tangible assets (%): -3.0442043419649503
Capex to operating income (%): 16.80445889456572
Buffett classification: The Great
Stock price: 4.02
P/E ratio: 6.16941552823315
Shares outstanding: 30331425
Book value: -78840000
Market cap (USD): 121932328.49999999
Debt to equity: -1.3685185185185185
Current ratio: 0.9795595306409166
Quick ratio: 0.7394977936957081
Effective tax rate (%): 35.390946502057616
Interest coverage ratio: 3.774544179523142
COGS to revenue (%): 28.395718641917195
SG&A to revenue (%): 49.57329676851606
Free cash flow (dilution-adjusted): 2938000
Buyback yield (%): 0
Retained earnings: -79478000
Inventory turnover: 1.143669634025717
Receivables turnover: 5.327409507195814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.839295258104347
FCF margin (%): 6.012729468104701
Revenue growth (%): -0.2633082952318746
Rule of 40 score: 5.749421172872826
Financial ratios for BTMD — quarterly report dated 2025-09-30
Total revenue: 47956000
Gross profit: 34418000
Operating income: 8267000
Net income: 9216000
Capital expenditures: 499000
Operating cash flow: 14072000
Depreciation & amortization: 952000
Net tangible assets: -86652000
Owner earnings: 9669000
Return on net tangible assets (%): -11.15842681069104
Capex to operating income (%): 6.036046933591387
Buffett classification: The Great
Stock price: 3
P/E ratio: 3.1398990683229813
Shares outstanding: 30331425
Book value: -65467000
Market cap (USD): 90994275
Debt to equity: -1.6253379565277162
Current ratio: 1.0144739646231442
Quick ratio: 0.7224017901541522
Effective tax rate (%): -9.052183173588926
Interest coverage ratio: 3.0248810830589097
COGS to revenue (%): 28.230044207189923
SG&A to revenue (%): 54.531236967219954
Free cash flow (dilution-adjusted): 10972000
Buyback yield (%): 3.6980348488957135
Retained earnings: -63760000
Inventory turnover: 0.8231788884835218
Receivables turnover: 5.768101996632186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.026537734477245
FCF margin (%): 22.879306030527985
Revenue growth (%): -1.8562102204121727
Rule of 40 score: 21.023095810115812
Financial ratios for BTMD — annual report dated 2025-12-31
Total revenue: 192219000
Gross profit: 137361000
Operating income: 35551000
Net income: 31597000
Capital expenditures: 5015000
Operating cash flow: 35194000
Depreciation & amortization: 3670000
Net tangible assets: -73163000
Owner earnings: 30252000
Return on net tangible assets (%): -41.34876918661072
Capex to operating income (%): 14.106494894658377
Buffett classification: The Great
Stock price: 2.6
P/E ratio: 2.4958605247333607
Shares outstanding: 30331425
Book value: -50397000
Market cap (USD): 78861705
Debt to equity: -2.1811218921761215
Current ratio: 1.2151319152719433
Quick ratio: 0.7914027249894423
Effective tax rate (%): 15.9296509152831
Interest coverage ratio: 3.243408448134294
COGS to revenue (%): 28.539322335461115
SG&A to revenue (%): 52.96562774751715
Free cash flow (dilution-adjusted): 19409000
Buyback yield (%): 4.2669632871873615
Retained earnings: -49549000
Inventory turnover: 2.8775702895509863
Receivables turnover: 25.03829620945682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 56.77078343074319
FCF margin (%): 10.097336891774486
Revenue growth (%): -2.521413249083376
Rule of 40 score: 7.57592364269111
Financial ratios for BTMD — quarterly report dated 2025-12-31
Total revenue: 46408000
Gross profit: 31573000
Operating income: 6829000
Net income: 2617000
Capital expenditures: 1077000
Operating cash flow: 7569000
Depreciation & amortization: 951000
Net tangible assets: -73163000
Owner earnings: 2491000
Return on net tangible assets (%): -3.404726432759728
Capex to operating income (%): 15.77097671694245
Buffett classification: The Great
Stock price: 2.6
P/E ratio: 2.4958605247333607
Shares outstanding: 30331425
Book value: -50397000
Market cap (USD): 78861705
Debt to equity: -2.1811218921761215
Current ratio: 1.2151319152719433
Quick ratio: 0.7914027249894423
Effective tax rate (%): 53.29287881492058
Interest coverage ratio: 2.763658437879401
COGS to revenue (%): 31.966471298052063
SG&A to revenue (%): 53.318393380451646
Free cash flow (dilution-adjusted): 3007000
Buyback yield (%): 0
Retained earnings: -49549000
Inventory turnover: 0.7781682752832564
Receivables turnover: 6.045069688680474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.905113218996519
FCF margin (%): 6.479486295466298
Revenue growth (%): -3.227958962382184
Rule of 40 score: 3.2515273330841143
Financial ratios for BZ.V — annual report dated 2022-04-30
Total revenue: 0
Operating income: -15868427.34375
Net income: -9781689.84375
Capital expenditures: 125596.875
Operating cash flow: -15718660.9375
Net tangible assets: 2745382.8125
Owner earnings: -9907286.71875
Return on net tangible assets (%): -360.87086557259494
Buffett classification: The Gruesome
Stock price: 0.6015625
Shares outstanding: 333857248
Book value: 2745382.8125
P/B ratio: 73.15409706638134
Market cap (USD): 200836000.75
Debt to equity: 0
Current ratio: 1.6631531373978452
Quick ratio: 1.6631531373978452
Free cash flow (dilution-adjusted): -15848159.375
Buyback yield (%): 0
Retained earnings: -22655104.6875
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -578.00417746842
Rule of 40 score: 0
Financial ratios for BZ.V — annual report dated 2023-04-30
Total revenue: 0
Operating income: -5053434.558823529
Net income: -3512472.058823529
Capital expenditures: 243117.64705882352
Operating cash flow: -5411861.764705882
Net tangible assets: 6445423.529411764
Owner earnings: -3755589.705882353
Return on net tangible assets (%): -58.267539576644445
Buffett classification: The Gruesome
Stock price: 0.21323529411764702
Shares outstanding: 333857248
Book value: 6445423.529411765
P/B ratio: 11.045069132498934
Market cap (USD): 71190148.47058822
Debt to equity: 0
Current ratio: 2.533919189457375
Quick ratio: 2.533919189457375
Free cash flow (dilution-adjusted): -5654979.411764706
Buyback yield (%): 0
Retained earnings: -22691198.529411763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.40345224427364
Rule of 40 score: 0
Financial ratios for BZ.V — annual report dated 2024-04-30
Total revenue: 0
Gross profit: 0
Operating income: -5211315.328467153
Net income: -2937577.3722627736
Capital expenditures: 985401.4598540146
Operating cash flow: -5436408.759124087
Depreciation & amortization: 0
Net tangible assets: 5297297.810218978
Owner earnings: -3922978.8321167883
Return on net tangible assets (%): -74.05622588461988
Buffett classification: The Gruesome
Stock price: 0.1094890510948905
Shares outstanding: 333857248
Book value: 5297297.810218978
P/B ratio: 6.900445207017818
Market cap (USD): 36553713.28467153
Debt to equity: 0
Current ratio: 10.238495544752173
Quick ratio: 10.238495544752173
Interest coverage ratio: -1576.3969971296092
Free cash flow (dilution-adjusted): -6738663.503649634
Buyback yield (%): 0
Retained earnings: -23589938.686131384
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -98.37686147103233
Rule of 40 score: 0
Financial ratios for BZ.V — quarterly report dated 2024-10-31
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.15827338129496404
Shares outstanding: 333857248
Market cap (USD): 52840715.51079137
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BZ.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: 0
Operating income: -1414652.4137931035
Net income: -1443566.8965517243
Capital expenditures: 306392.4137931035
Operating cash flow: -835502.0689655172
Depreciation & amortization: 0
Net tangible assets: 12926039.310344828
Owner earnings: -1749959.3103448278
Return on net tangible assets (%): -13.538248401769282
Buffett classification: The Gruesome
Stock price: 0.22068965517241382
Shares outstanding: 333857248
Book value: 12926039.310344828
P/B ratio: 5.700032250324752
Market cap (USD): 73678840.93793105
Debt to equity: 0
Current ratio: 4.909591951509093
Quick ratio: 4.909591951509093
Interest coverage ratio: -1415.6287094547963
Free cash flow (dilution-adjusted): -1645942.7586206896
Buyback yield (%): 0
Retained earnings: -24332755.862068966
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.94420634061467
Rule of 40 score: 0
Financial ratios for BZ.V — annual report dated 2025-04-30
Total revenue: 0
Gross profit: -6837.68115942029
Operating income: -5409160.869565218
Net income: -5437818.115942029
Capital expenditures: 692646.3768115942
Operating cash flow: -2379047.1014492754
Depreciation & amortization: 6837.68115942029
Net tangible assets: 16590126.811594205
Owner earnings: -6123626.811594203
Return on net tangible assets (%): -36.91127187354972
Buffett classification: The Gruesome
Stock price: 0.24637681159420294
Shares outstanding: 333857248
Book value: 16590126.811594205
P/B ratio: 4.9580503647730065
Market cap (USD): 82254684.2898551
Debt to equity: 0.006691468974365973
Current ratio: 8.347822188557641
Quick ratio: 8.347822188557641
Interest coverage ratio: -361.4313659032586
Free cash flow (dilution-adjusted): -4614630.434782609
Buyback yield (%): 0
Retained earnings: -28855976.086956523
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.771465053749587
Rule of 40 score: 0
Financial ratios for BZ.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -3230774.6376811597
Net income: -3288950.0000000005
Capital expenditures: 370712.3188405797
Operating cash flow: -1266623.9130434783
Net tangible assets: 16590126.811594205
Owner earnings: -3659662.31884058
Return on net tangible assets (%): -22.059278752968797
Buffett classification: The Gruesome
Stock price: 0.24637681159420294
Shares outstanding: 333857248
Book value: 16590126.811594205
P/B ratio: 4.9580503647730065
Market cap (USD): 82254684.2898551
Debt to equity: 0.006691468974365973
Current ratio: 8.347822188557641
Quick ratio: 8.347822188557641
Interest coverage ratio: -360.16390661604333
Free cash flow (dilution-adjusted): -2566868.8405797104
Buyback yield (%): 0
Retained earnings: -28855976.086956523
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.379129639000215
Rule of 40 score: 0
Financial ratios for BZ.V — quarterly report dated 2025-07-31
Total revenue: 0
Gross profit: -12263.76811594203
Operating income: -2692280.434782609
Net income: -2591015.2173913047
Capital expenditures: 87578.26086956523
Operating cash flow: -2142481.15942029
Depreciation & amortization: 12263.76811594203
Net tangible assets: 15451655.797101451
Owner earnings: -2666329.710144928
Return on net tangible assets (%): -17.255948133695163
Buffett classification: The Gruesome
Stock price: 0.4565217391304348
Shares outstanding: 333857248
Book value: 15451655.79710145
P/B ratio: 9.86386789089955
Market cap (USD): 152413091.47826087
Debt to equity: 0.006697936082550133
Current ratio: 4.958365007015783
Quick ratio: 4.958365007015783
Interest coverage ratio: -200.91645035691107
Free cash flow (dilution-adjusted): -2230059.4202898555
Buyback yield (%): 0
Retained earnings: -31446991.304347828
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.38023695381972
Rule of 40 score: 0
Financial ratios for BZ.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -13433.57142857143
Operating income: -6704925.714285715
Net income: -5829647.142857144
Capital expenditures: 774596.4285714286
Operating cash flow: -5185172.857142857
Depreciation & amortization: 13433.57142857143
Net tangible assets: 27353417.142857146
Owner earnings: -6590810
Return on net tangible assets (%): -24.095015133131444
Buffett classification: The Gruesome
Stock price: 1.0357142857142858
Shares outstanding: 333857248
Book value: 27353417.142857146
P/B ratio: 12.641225750222276
Market cap (USD): 345780721.1428572
Debt to equity: 0.00324545504682831
Current ratio: 6.287769858337057
Quick ratio: 6.287769858337057
Interest coverage ratio: -846.0474087426768
Free cash flow (dilution-adjusted): -5959769.285714286
Buyback yield (%): 0
Retained earnings: -36827395.71428572
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.678055793906864
Rule of 40 score: 0
Financial ratios for CAN.AX — annual report dated 2021-06-30
Total revenue: 3227819.5488721803
Gross profit: 3191729.3233082704
Operating income: -17703007.51879699
Net income: -18874436.090225562
Capital expenditures: 11813533.834586466
Depreciation & amortization: 1978195.4887218045
Net tangible assets: 67538345.86466165
Owner earnings: -28709774.436090223
Return on net tangible assets (%): -42.508850444192106
Buffett classification: The Gruesome
Stock price: 0.2556390977443609
Shares outstanding: 1660593585
Book value: 69076691.7293233
P/B ratio: 6.14552659025601
Market cap (USD): 424512645.78947365
Debt to equity: 0.007401602229188437
Current ratio: 2.2895636853559953
Quick ratio: 0.95315576743704
Interest coverage ratio: -5.6721271982654775
COGS to revenue (%): 1.1180992313067784
R&D to revenue (%): 47.30957372466806
SG&A to revenue (%): 499.60400652224547
Free cash flow (dilution-adjusted): -27894736.842105262
Buyback yield (%): 0.0506551680186236
Retained earnings: -45987969.92481203
Inventory turnover: 0.003722373012795657
Receivables turnover: 1.023117254528122
Capitalized R&D asset: 1527067.6691729322
ROCI (R&D-adjusted, %): -23.56382865759127
FCF margin (%): -864.1975308641975
Rule of 40 score: -864.1975308641975
Financial ratios for CAN.AX — annual report dated 2022-06-30
Total revenue: 4421379.310344827
Gross profit: 4421379.310344827
Operating income: -20051034.482758623
Net income: -18253793.103448275
Capital expenditures: 31147586.20689655
Depreciation & amortization: 3308275.8620689656
Net tangible assets: 57545517.24137931
Owner earnings: -46093103.448275864
Return on net tangible assets (%): -80.09851272156374
Buffett classification: The Gruesome
Stock price: 0.18620689655172415
Shares outstanding: 1660593585
Book value: 58553793.10344828
P/B ratio: 5.280853067029433
Market cap (USD): 309213977.8965517
Debt to equity: 0.5555162950661342
Current ratio: 1.696283185840708
Quick ratio: 0.682566371681416
Interest coverage ratio: -15.904814004376368
COGS to revenue (%): 0
R&D to revenue (%): 46.65418811417876
SG&A to revenue (%): 391.9981282171268
Free cash flow (dilution-adjusted): -45239310.344827585
Buyback yield (%): 0
Retained earnings: -58234482.758620694
Inventory turnover: 0
Receivables turnover: 1.5418470418470416
Capitalized R&D asset: 3085893.9590355195
ROCI (R&D-adjusted, %): -20.94143071295635
Rosenberg metric: 0.8052360821066573
FCF margin (%): -1023.1945094369053
Revenue growth (%): 36.97727656088098
Rule of 40 score: -986.2172328760242
Financial ratios for CAN.AX — annual report dated 2023-06-30
Total revenue: 9123841.05960265
Gross profit: 9123841.05960265
Operating income: -24227152.317880794
Net income: -22377483.44370861
Capital expenditures: 18543.046357615895
Depreciation & amortization: 7920529.8013245035
Net tangible assets: 39103311.25827815
Owner earnings: -14475496.688741723
Return on net tangible assets (%): -37.01859567117163
Buffett classification: The Gruesome
Stock price: 0.07947019867549669
Shares outstanding: 1660593585
Book value: 39245695.36423841
P/B ratio: 3.3626032331550264
Market cap (USD): 131967702.11920531
Debt to equity: 1.0287541553466866
Current ratio: 0.8691125230580037
Quick ratio: 0.3691740110678418
Interest coverage ratio: -11.584230525649145
COGS to revenue (%): 0
R&D to revenue (%): 31.131596138491684
SG&A to revenue (%): 240.90150250417364
Free cash flow (dilution-adjusted): -17176158.940397352
Buyback yield (%): 0
Retained earnings: -78298013.24503312
Inventory turnover: 0
Receivables turnover: 2.441431862484494
Capitalized R&D asset: 4726377.957682515
ROCI (R&D-adjusted, %): -31.66494323299719
Rosenberg metric: 2.2796955989380954
FCF margin (%): -188.2557886332293
Revenue growth (%): 106.3573473159233
Rule of 40 score: -81.89844131730598
Financial ratios for CKA.AX — annual report dated 2021-06-30
Operating income: -1987899.2481203007
Net income: -2027688.7218045113
Capital expenditures: 230887.96992481203
Net tangible assets: 4895707.5187969925
Owner earnings: -2258576.6917293235
Return on net tangible assets (%): -46.133815859251264
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 1078948980
Book value: 4895707.518796992
P/B ratio: 9.942258578214368
Market cap (USD): 48674390.075187966
Debt to equity: 0.6076157554623193
Current ratio: 0.02476857533618254
Quick ratio: 0.02476857533618254
Interest coverage ratio: -46.94935540007814
Free cash flow (dilution-adjusted): -1627190.2255639096
Buyback yield (%): 0
Retained earnings: -71529169.17293233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.369618064488954
Rule of 40 score: 0
Financial ratios for CKA.AX — annual report dated 2022-06-30
Operating income: -4826155.172413793
Net income: -4916197.24137931
Capital expenditures: 2735177.931034483
Depreciation & amortization: 130131.03448275862
Net tangible assets: -19372.41379310345
Owner earnings: -7521244.137931035
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 1078948980
Book value: -19372.413793101907
Market cap (USD): 104174384.27586208
Debt to equity: -574.5150231399532
Current ratio: 0.040975251280106206
Quick ratio: 0.040975251280106206
Interest coverage ratio: -184.5882461554694
Free cash flow (dilution-adjusted): -8577434.48275862
Buyback yield (%): 0
Retained earnings: -70525711.03448276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.085671894536965
Rule of 40 score: 0